Aegis is a biotechnology company that commercializes its patented drug delivery and protein stabilization technologies to pharmaceutical companies... Read more
Aegis is a biotechnology company that commercializes its patented drug delivery and protein stabilization technologies to pharmaceutical companies... Read more
News
Nov 20, 2024
Global Legal Chronicle
Aegis Therapeutics: OrbiMed Advisors' $208 Million Acquisition of Neurelis
Dec 04, 2018
pipelinereview
Aegis Therapeutics: Neurelis Announces Acquisition Of Aegis Therapeutics, A Leading Drug Delivery Technology Company
Dec 03, 2018
San Diego Business Journal
Aegis Therapeutics: Neurelis Buys Aegis Therapeutics
Aug 15, 2018
GlobeNewswire
Press Release: Aegis Therapeutics : Aegis is Awarded US Patent for Formulation and Non-invasive Delivery of Peptide Drugs
Aug 02, 2018
Benzinga
Aegis Therapeutics: Aegis Expands its International and US Intravail® Patent Portfolio on Multiple Fronts
Aug 01, 2018
BioPortfolio
Aegis Therapeutics: Aegis Therapeutics LLC Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12042018 Prices from USD $250
Mar 29, 2018
MarketersMedia
Press Release: Aegis : Snapshot of the Global Therapeutic Landscape of Acromegaly to Deliver by Research Available at The Market Reports
Feb 22, 2018
GlobeNewswire
Press Release: Aegis : Aegis Awarded Patent for Fast Acting Nasal Spray Opioid Blockers and Pain Medications
Oct 11, 2017
OINDPnews
Aegis: Aegis Therapeutics announces availability of intranasal hydromorphone formulation
Oct 10, 2017
BioSpace
Aegis: Aegis Therapeutics, LLC Announces Breakthrough In Non-Invasive, Rapid Onset, Acute Pain Control
Aegis Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10